Skip to main content
Top
Published in: BMC Medicine 1/2011

Open Access 01-12-2011 | Opinion

Friedreich's ataxia: the vicious circle hypothesis revisited

Authors: Aurélien Bayot, Renata Santos, Jean-Michel Camadro, Pierre Rustin

Published in: BMC Medicine | Issue 1/2011

Login to get access

Abstract

Friedreich's ataxia, the most frequent progressive autosomal recessive disorder involving the central and peripheral nervous systems, is mostly associated with unstable expansion of GAA trinucleotide repeats in the first intron of the FXN gene, which encodes the mitochondrial frataxin protein. Since FXN was shown to be involved in Friedreich's ataxia in the late 1990s, the consequence of frataxin loss of function has generated vigorous debate. Very early on we suggested a unifying hypothesis according to which frataxin deficiency leads to a vicious circle of faulty iron handling, impaired iron-sulphur cluster synthesis and increased oxygen radical production. However, data from cell and animal models now indicate that iron accumulation is an inconsistent and late event and that frataxin deficiency does not always impair the activity of iron-sulphur cluster-containing proteins. In contrast, frataxin deficiency appears to be consistently associated with increased sensitivity to reactive oxygen species as opposed to increased oxygen radical production. By compiling the findings of fundamental research and clinical observations we defend here the opinion that the very first consequence of frataxin depletion is indeed an abnormal oxidative status which initiates the pathogenic mechanism underlying Friedreich's ataxia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schulz JB, Boesch S, Bürk K, Dürr A, Giunti P, Mariotti C, Pousset F, Schöls L, Vankan P, Pandolfo M: Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol. 2009, 5: 222-234. 10.1038/nrneurol.2009.26.CrossRefPubMed Schulz JB, Boesch S, Bürk K, Dürr A, Giunti P, Mariotti C, Pousset F, Schöls L, Vankan P, Pandolfo M: Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol. 2009, 5: 222-234. 10.1038/nrneurol.2009.26.CrossRefPubMed
2.
go back to reference Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Cañizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, Pandolfo M: Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996, 271: 1423-1427. 10.1126/science.271.5254.1423.CrossRefPubMed Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, Zara F, Cañizares J, Koutnikova H, Bidichandani SI, Gellera C, Brice A, Trouillas P, De Michele G, Filla A, De Frutos R, Palau F, Patel PI, Di Donato S, Mandel JL, Cocozza S, Koenig M, Pandolfo M: Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996, 271: 1423-1427. 10.1126/science.271.5254.1423.CrossRefPubMed
3.
go back to reference Gerber J, Mühlenhoff U, Lill R: An interaction between frataxin and Isu1/Nfs1 that is crucial for Fe/S cluster synthesis on Isu1. EMBO Rep. 2003, 4: 906-911. 10.1038/sj.embor.embor918.CrossRefPubMedPubMedCentral Gerber J, Mühlenhoff U, Lill R: An interaction between frataxin and Isu1/Nfs1 that is crucial for Fe/S cluster synthesis on Isu1. EMBO Rep. 2003, 4: 906-911. 10.1038/sj.embor.embor918.CrossRefPubMedPubMedCentral
4.
go back to reference Rötig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P: Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997, 17: 215-217. 10.1038/ng1097-215.CrossRefPubMed Rötig A, de Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, Rustin P: Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet. 1997, 17: 215-217. 10.1038/ng1097-215.CrossRefPubMed
5.
go back to reference Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F, Cortopassi G: The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet. 1999, 8: 425-430. 10.1093/hmg/8.3.425.CrossRefPubMed Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F, Cortopassi G: The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet. 1999, 8: 425-430. 10.1093/hmg/8.3.425.CrossRefPubMed
6.
go back to reference Chantrel-Groussard K, Geromel V, Puccio H, Koenig M, Munnich A, Rötig A, Rustin P: Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Hum Mol Genet. 2001, 10: 2061-2067. 10.1093/hmg/10.19.2061.CrossRefPubMed Chantrel-Groussard K, Geromel V, Puccio H, Koenig M, Munnich A, Rötig A, Rustin P: Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Hum Mol Genet. 2001, 10: 2061-2067. 10.1093/hmg/10.19.2061.CrossRefPubMed
7.
go back to reference Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR: Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004, 5: 863-873.CrossRefPubMed Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR: Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004, 5: 863-873.CrossRefPubMed
8.
go back to reference Jiralerspong S, Ge B, Hudson TJ, Pandolfo M: Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells. FEBS Lett. 2001, 509: 101-105. 10.1016/S0014-5793(01)03140-4.CrossRefPubMed Jiralerspong S, Ge B, Hudson TJ, Pandolfo M: Manganese superoxide dismutase induction by iron is impaired in Friedreich ataxia cells. FEBS Lett. 2001, 509: 101-105. 10.1016/S0014-5793(01)03140-4.CrossRefPubMed
9.
go back to reference Paupe V, Dassa EP, Goncalves S, Auchère F, Lönn M, Holmgren A, Rustin P: Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS One. 2009, 4: e4253-10.1371/journal.pone.0004253.CrossRefPubMedPubMedCentral Paupe V, Dassa EP, Goncalves S, Auchère F, Lönn M, Holmgren A, Rustin P: Impaired nuclear Nrf2 translocation undermines the oxidative stress response in Friedreich ataxia. PLoS One. 2009, 4: e4253-10.1371/journal.pone.0004253.CrossRefPubMedPubMedCentral
10.
go back to reference Bulteau AL, Dancis A, Gareil M, Montagne JJ, Camadro JM, Lesuisse E: Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia. Free Radic Biol Med. 2007, 42: 1561-1570. 10.1016/j.freeradbiomed.2007.02.014.CrossRefPubMed Bulteau AL, Dancis A, Gareil M, Montagne JJ, Camadro JM, Lesuisse E: Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia. Free Radic Biol Med. 2007, 42: 1561-1570. 10.1016/j.freeradbiomed.2007.02.014.CrossRefPubMed
11.
go back to reference Gibson TJ, Koonin EV, Musco G, Pastore A, Bork P: Friedreich's ataxia protein: phylogenetic evidence for mitochondrial dysfunction. Trends Neurosci. 1996, 19: 465-468. 10.1016/S0166-2236(96)20054-2.CrossRefPubMed Gibson TJ, Koonin EV, Musco G, Pastore A, Bork P: Friedreich's ataxia protein: phylogenetic evidence for mitochondrial dysfunction. Trends Neurosci. 1996, 19: 465-468. 10.1016/S0166-2236(96)20054-2.CrossRefPubMed
12.
go back to reference Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, Kaplan J: Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997, 276: 1709-1712. 10.1126/science.276.5319.1709.CrossRefPubMed Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, Kaplan J: Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science. 1997, 276: 1709-1712. 10.1126/science.276.5319.1709.CrossRefPubMed
13.
go back to reference Rustin P, Munnich A, Rötig A: Quinone analogs prevent enzymes targeted in Friedreich ataxia from iron-induced injury in vitro. Biofactors. 1999, 9: 247-251. 10.1002/biof.5520090220.CrossRefPubMed Rustin P, Munnich A, Rötig A: Quinone analogs prevent enzymes targeted in Friedreich ataxia from iron-induced injury in vitro. Biofactors. 1999, 9: 247-251. 10.1002/biof.5520090220.CrossRefPubMed
14.
go back to reference Sturm B, Bistrich U, Schranzhofer M, Sarsero JP, Rauen U, Scheiber-Mojdehkar B, de Groot H, Ioannou P, Petrat F: Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?. J Biol Chem. 2005, 280: 6701-6708. 10.1074/jbc.M408717200.CrossRefPubMed Sturm B, Bistrich U, Schranzhofer M, Sarsero JP, Rauen U, Scheiber-Mojdehkar B, de Groot H, Ioannou P, Petrat F: Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?. J Biol Chem. 2005, 280: 6701-6708. 10.1074/jbc.M408717200.CrossRefPubMed
15.
go back to reference Seguin A, Sutak R, Bulteau AL, Garcia-Serres R, Oddou JL, Lefevre S, Santos R, Dancis A, Camadro JM, Latour JM, Lesuisse E: Evidence that yeast frataxin is not an iron storage protein in vivo. Biochim Biophys Acta. 2010, 1802: 531-538.CrossRefPubMed Seguin A, Sutak R, Bulteau AL, Garcia-Serres R, Oddou JL, Lefevre S, Santos R, Dancis A, Camadro JM, Latour JM, Lesuisse E: Evidence that yeast frataxin is not an iron storage protein in vivo. Biochim Biophys Acta. 2010, 1802: 531-538.CrossRefPubMed
16.
go back to reference Puccio H, Simon D, Cossée M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, Koenig M: Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 2001, 27: 181-186. 10.1038/84818.CrossRefPubMed Puccio H, Simon D, Cossée M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, Koenig M: Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 2001, 27: 181-186. 10.1038/84818.CrossRefPubMed
17.
go back to reference Schulz JB, Dehmer T, Schöls L, Mende H, Hardt C, Vorgerd M, Burk K, Matson W, Dichgans J, Beal MF, Bogdanov MB: Oxidative stress in patients with Friedreich ataxia. Neurology. 2000, 55: 1719-1721.CrossRefPubMed Schulz JB, Dehmer T, Schöls L, Mende H, Hardt C, Vorgerd M, Burk K, Matson W, Dichgans J, Beal MF, Bogdanov MB: Oxidative stress in patients with Friedreich ataxia. Neurology. 2000, 55: 1719-1721.CrossRefPubMed
18.
go back to reference Seznec H, Simon D, Bouton C, Reutenauer L, Hertzog A, Golik P, Procaccio V, Patel M, Drapier JC, Koenig M, Puccio H: Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet. 2005, 14: 463-474.CrossRefPubMed Seznec H, Simon D, Bouton C, Reutenauer L, Hertzog A, Golik P, Procaccio V, Patel M, Drapier JC, Koenig M, Puccio H: Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet. 2005, 14: 463-474.CrossRefPubMed
19.
go back to reference Santos R, Lefevre S, Sliwa D, Seguin A, Camadro JM, Lesuisse E: Friedreich's ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid Redox Signal. 2010, 13: 651-690. 10.1089/ars.2009.3015.CrossRefPubMedPubMedCentral Santos R, Lefevre S, Sliwa D, Seguin A, Camadro JM, Lesuisse E: Friedreich's ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid Redox Signal. 2010, 13: 651-690. 10.1089/ars.2009.3015.CrossRefPubMedPubMedCentral
20.
go back to reference Al-Mahdawi S, Pinto RM, Varshney D, Lawrence L, Lowrie MB, Hughes S, Webster Z, Blake J, Cooper JM, King R, Pook MA: GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics. 2006, 88: 580-590. 10.1016/j.ygeno.2006.06.015.CrossRefPubMedPubMedCentral Al-Mahdawi S, Pinto RM, Varshney D, Lawrence L, Lowrie MB, Hughes S, Webster Z, Blake J, Cooper JM, King R, Pook MA: GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics. 2006, 88: 580-590. 10.1016/j.ygeno.2006.06.015.CrossRefPubMedPubMedCentral
21.
go back to reference Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, Piemonte F: Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem. 2003, 278: 42588-42595. 10.1074/jbc.M301872200.CrossRefPubMed Pastore A, Tozzi G, Gaeta LM, Bertini E, Serafini V, Di Cesare S, Bonetto V, Casoni F, Carrozzo R, Federici G, Piemonte F: Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: a potential role in the pathogenesis of the disease. J Biol Chem. 2003, 278: 42588-42595. 10.1074/jbc.M301872200.CrossRefPubMed
22.
go back to reference Marmolino D, Manto M, Acquaviva F, Vergara P, Ravella A, Monticelli A, Pandolfo M: PGC-1α down-regulation affects the antioxidant response in Friedreich's ataxia. PLoS One. 2010, 5: e10025-10.1371/journal.pone.0010025.CrossRefPubMedPubMedCentral Marmolino D, Manto M, Acquaviva F, Vergara P, Ravella A, Monticelli A, Pandolfo M: PGC-1α down-regulation affects the antioxidant response in Friedreich's ataxia. PLoS One. 2010, 5: e10025-10.1371/journal.pone.0010025.CrossRefPubMedPubMedCentral
23.
go back to reference Mochel F, Knight MA, Tong WH, Hernandez D, Ayyad K, Taivassalo T, Andersen PM, Singleton A, Rouault TA, Fischbeck KH, Haller RG: Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance. Am J Hum Genet. 2008, 82: 652-660. 10.1016/j.ajhg.2007.12.012.CrossRefPubMedPubMedCentral Mochel F, Knight MA, Tong WH, Hernandez D, Ayyad K, Taivassalo T, Andersen PM, Singleton A, Rouault TA, Fischbeck KH, Haller RG: Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes myopathy with exercise intolerance. Am J Hum Genet. 2008, 82: 652-660. 10.1016/j.ajhg.2007.12.012.CrossRefPubMedPubMedCentral
24.
go back to reference Sanaker PS, Toompuu M, Hogan VE, He L, Tzoulis C, Chrzanowska-Lightowlers ZM, Taylor RW, Bindoff LA: Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy. Biochim Biophys Acta. 2010, 1802: 539-544.CrossRefPubMed Sanaker PS, Toompuu M, Hogan VE, He L, Tzoulis C, Chrzanowska-Lightowlers ZM, Taylor RW, Bindoff LA: Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy. Biochim Biophys Acta. 2010, 1802: 539-544.CrossRefPubMed
25.
go back to reference Gakh O, Bedekovics T, Duncan SF, Smith DY, Berkholz DS, Isaya G: Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly. J Biol Chem. 2010, 285: 38486-38501. 10.1074/jbc.M110.145144.CrossRefPubMedPubMedCentral Gakh O, Bedekovics T, Duncan SF, Smith DY, Berkholz DS, Isaya G: Normal and Friedreich ataxia cells express different isoforms of frataxin with complementary roles in iron-sulfur cluster assembly. J Biol Chem. 2010, 285: 38486-38501. 10.1074/jbc.M110.145144.CrossRefPubMedPubMedCentral
26.
go back to reference Gallagher CL, Waclawik AJ, Beinlich BR, Harding CO, Pauli RM, Poirer J, Pandolfo M, Salamat MS: Friedreich's ataxia associated with mitochondrial myopathy: clinicopathologic report. J Child Neurol. 2002, 17: 453-456. 10.1177/088307380201700612.CrossRefPubMed Gallagher CL, Waclawik AJ, Beinlich BR, Harding CO, Pauli RM, Poirer J, Pandolfo M, Salamat MS: Friedreich's ataxia associated with mitochondrial myopathy: clinicopathologic report. J Child Neurol. 2002, 17: 453-456. 10.1177/088307380201700612.CrossRefPubMed
27.
go back to reference Wingert RA, Galloway JL, Barut B, Foott H, Fraenkel P, Axe JL, Weber GJ, Dooley K, Davidson AJ, Schmid B, Paw BH, Shaw GC, Kingsley P, Palis J, Schubert H, Chen O, Kaplan J, Zon LI, Tübingen 2000 Screen Consortium: Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005, 436: 1035-1039. 10.1038/nature03887.CrossRefPubMed Wingert RA, Galloway JL, Barut B, Foott H, Fraenkel P, Axe JL, Weber GJ, Dooley K, Davidson AJ, Schmid B, Paw BH, Shaw GC, Kingsley P, Palis J, Schubert H, Chen O, Kaplan J, Zon LI, Tübingen 2000 Screen Consortium: Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005, 436: 1035-1039. 10.1038/nature03887.CrossRefPubMed
28.
go back to reference Camaschella C, Campanella A, De Falco L, Boschetto L, Merlini R, Silvestri L, Levi S, Iolascon A: The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood. 2007, 110: 1353-1358. 10.1182/blood-2007-02-072520.CrossRefPubMed Camaschella C, Campanella A, De Falco L, Boschetto L, Merlini R, Silvestri L, Levi S, Iolascon A: The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood. 2007, 110: 1353-1358. 10.1182/blood-2007-02-072520.CrossRefPubMed
29.
go back to reference Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM: Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet. 1999, 8: 743-749. 10.1093/hmg/8.5.743.CrossRefPubMed Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM: Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A). Hum Mol Genet. 1999, 8: 743-749. 10.1093/hmg/8.5.743.CrossRefPubMed
30.
go back to reference Maguire A, Hellier K, Hammans S, May A: X-linked cerebellar ataxia and sideroblastic anaemia associated with a missense mutation in the ABC7 gene predicting V411L. Br J Haematol. 2001, 115: 910-917. 10.1046/j.1365-2141.2001.03015.x.CrossRefPubMed Maguire A, Hellier K, Hammans S, May A: X-linked cerebellar ataxia and sideroblastic anaemia associated with a missense mutation in the ABC7 gene predicting V411L. Br J Haematol. 2001, 115: 910-917. 10.1046/j.1365-2141.2001.03015.x.CrossRefPubMed
31.
go back to reference Bekri S, Kispal G, Lange H, Fitzsimons E, Tolmie J, Lill R, Bishop DF: Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. Blood. 2000, 96: 3256-3264.PubMed Bekri S, Kispal G, Lange H, Fitzsimons E, Tolmie J, Lill R, Bishop DF: Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. Blood. 2000, 96: 3256-3264.PubMed
32.
go back to reference Miao R, Kim H, Koppolu UM, Ellis EA, Scott RA, Lindahl PA: Biophysical characterization of the iron in mitochondria from Atm1p-depleted Saccharomyces cerevisiae. Biochemistry. 2009, 48: 9556-9568. 10.1021/bi901110n.CrossRefPubMedPubMedCentral Miao R, Kim H, Koppolu UM, Ellis EA, Scott RA, Lindahl PA: Biophysical characterization of the iron in mitochondria from Atm1p-depleted Saccharomyces cerevisiae. Biochemistry. 2009, 48: 9556-9568. 10.1021/bi901110n.CrossRefPubMedPubMedCentral
33.
go back to reference Burke MA, Ardehali H: Mitochondrial ATP-binding cassette proteins. Transl Res. 2007, 150: 73-80. 10.1016/j.trsl.2007.03.002.CrossRefPubMed Burke MA, Ardehali H: Mitochondrial ATP-binding cassette proteins. Transl Res. 2007, 150: 73-80. 10.1016/j.trsl.2007.03.002.CrossRefPubMed
34.
go back to reference Di Donato I, Bianchi S, Federico A: Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol Sci. 2010, 31: 511-515. 10.1007/s10072-010-0261-1.CrossRefPubMed Di Donato I, Bianchi S, Federico A: Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol Sci. 2010, 31: 511-515. 10.1007/s10072-010-0261-1.CrossRefPubMed
35.
go back to reference Marzouki N, Benomar A, Yahyaoui M, Birouk N, Elouazzani M, Chkili T, Benlemlih M: Vitamin E deficiency ataxia with (744 del A) mutation on α-TTP gene: genetic and clinical peculiarities in Moroccan patients. Eur J Med Genet. 2005, 48: 21-28. 10.1016/j.ejmg.2005.01.014.CrossRefPubMed Marzouki N, Benomar A, Yahyaoui M, Birouk N, Elouazzani M, Chkili T, Benlemlih M: Vitamin E deficiency ataxia with (744 del A) mutation on α-TTP gene: genetic and clinical peculiarities in Moroccan patients. Eur J Med Genet. 2005, 48: 21-28. 10.1016/j.ejmg.2005.01.014.CrossRefPubMed
37.
go back to reference Armstrong JS, Khdour O, Hecht SM: Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question. FASEB J. 2010, 24: 2152-2163. 10.1096/fj.09-143222.CrossRefPubMed Armstrong JS, Khdour O, Hecht SM: Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question. FASEB J. 2010, 24: 2152-2163. 10.1096/fj.09-143222.CrossRefPubMed
39.
go back to reference Lill R, Mühlenhoff U: Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu Rev Biochem. 2008, 77: 669-700. 10.1146/annurev.biochem.76.052705.162653.CrossRefPubMed Lill R, Mühlenhoff U: Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu Rev Biochem. 2008, 77: 669-700. 10.1146/annurev.biochem.76.052705.162653.CrossRefPubMed
40.
go back to reference Prischi F, Konarev PV, Iannuzzi C, Pastore C, Adinolfi S, Martin SR, Svergun DI, Pastore A: Structural bases for the interaction of frataxin with the central components of iron-sulphur cluster assembly. Nat Commun. 2010, 1: 95-10.1038/ncomms1097.CrossRefPubMedPubMedCentral Prischi F, Konarev PV, Iannuzzi C, Pastore C, Adinolfi S, Martin SR, Svergun DI, Pastore A: Structural bases for the interaction of frataxin with the central components of iron-sulphur cluster assembly. Nat Commun. 2010, 1: 95-10.1038/ncomms1097.CrossRefPubMedPubMedCentral
41.
go back to reference Moreno-Cermeño A, Obis E, Bellí G, Cabiscol E, Ros J, Tamarit J: Frataxin depletion in yeast triggers up-regulation of iron transport systems before affecting iron-sulfur enzyme activities. J Biol Chem. 2010, 285: 41653-41664. 10.1074/jbc.M110.149443.CrossRefPubMedPubMedCentral Moreno-Cermeño A, Obis E, Bellí G, Cabiscol E, Ros J, Tamarit J: Frataxin depletion in yeast triggers up-regulation of iron transport systems before affecting iron-sulfur enzyme activities. J Biol Chem. 2010, 285: 41653-41664. 10.1074/jbc.M110.149443.CrossRefPubMedPubMedCentral
42.
go back to reference Gakh O, Park S, Liu G, Macomber L, Imlay JA, Ferreira GC, Isaya G: Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum Mol Genet. 2006, 15: 467-479.CrossRefPubMed Gakh O, Park S, Liu G, Macomber L, Imlay JA, Ferreira GC, Isaya G: Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum Mol Genet. 2006, 15: 467-479.CrossRefPubMed
43.
go back to reference Campanella A, Isaya G, O'Neill HA, Santambrogio P, Cozzi A, Arosio P, Levi S: The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. Hum Mol Genet. 2004, 13: 2279-2288. 10.1093/hmg/ddh232.CrossRefPubMed Campanella A, Isaya G, O'Neill HA, Santambrogio P, Cozzi A, Arosio P, Levi S: The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. Hum Mol Genet. 2004, 13: 2279-2288. 10.1093/hmg/ddh232.CrossRefPubMed
44.
go back to reference Condò I, Malisan F, Guccini I, Serio D, Rufini A, Testi R: Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin. Hum Mol Genet. 2010, 19: 1221-1229. 10.1093/hmg/ddp592.CrossRefPubMed Condò I, Malisan F, Guccini I, Serio D, Rufini A, Testi R: Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin. Hum Mol Genet. 2010, 19: 1221-1229. 10.1093/hmg/ddp592.CrossRefPubMed
45.
go back to reference González-Cabo P, Vázquez-Manrique RP, García-Gimeno MA, Sanz P, Palau F: Frataxin interacts functionally with mitochondrial electron transport chain proteins. Hum Mol Genet. 2005, 14: 2091-2098. 10.1093/hmg/ddi214.CrossRefPubMed González-Cabo P, Vázquez-Manrique RP, García-Gimeno MA, Sanz P, Palau F: Frataxin interacts functionally with mitochondrial electron transport chain proteins. Hum Mol Genet. 2005, 14: 2091-2098. 10.1093/hmg/ddi214.CrossRefPubMed
46.
go back to reference Cook JD, Kondapalli KC, Rawat S, Childs WC, Murugesan Y, Dancis A, Stemmler TL: Molecular details of the yeast frataxin-Isu1 interaction during mitochondrial Fe-S cluster assembly. Biochemistry. 2010, 49: 8756-8765. 10.1021/bi1008613.CrossRefPubMedPubMedCentral Cook JD, Kondapalli KC, Rawat S, Childs WC, Murugesan Y, Dancis A, Stemmler TL: Molecular details of the yeast frataxin-Isu1 interaction during mitochondrial Fe-S cluster assembly. Biochemistry. 2010, 49: 8756-8765. 10.1021/bi1008613.CrossRefPubMedPubMedCentral
47.
go back to reference Adinolfi S, Iannuzzi C, Prischi F, Pastore C, Iametti S, Martin SR, Bonomi F, Pastore A: Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nat Struct Mol Biol. 2009, 16: 390-396. 10.1038/nsmb.1579.CrossRefPubMed Adinolfi S, Iannuzzi C, Prischi F, Pastore C, Iametti S, Martin SR, Bonomi F, Pastore A: Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nat Struct Mol Biol. 2009, 16: 390-396. 10.1038/nsmb.1579.CrossRefPubMed
48.
go back to reference Coppola G, Marmolino D, Lu D, Wang Q, Cnop M, Rai M, Acquaviva F, Cocozza S, Pandolfo M, Geschwind DH: Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich's ataxia. Hum Mol Genet. 2009, 18: 2452-2461. 10.1093/hmg/ddp183.CrossRefPubMedPubMedCentral Coppola G, Marmolino D, Lu D, Wang Q, Cnop M, Rai M, Acquaviva F, Cocozza S, Pandolfo M, Geschwind DH: Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich's ataxia. Hum Mol Genet. 2009, 18: 2452-2461. 10.1093/hmg/ddp183.CrossRefPubMedPubMedCentral
49.
go back to reference Shidara Y, Hollenbeck PJ: Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia. J Neurosci. 2010, 30: 11369-11378. 10.1523/JNEUROSCI.0529-10.2010.CrossRefPubMedPubMedCentral Shidara Y, Hollenbeck PJ: Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia. J Neurosci. 2010, 30: 11369-11378. 10.1523/JNEUROSCI.0529-10.2010.CrossRefPubMedPubMedCentral
50.
go back to reference Vázquez-Manrique RP, González-Cabo P, Ros S, Aziz H, Baylis HA, Palau F: Reduction of Caenorhabditis elegans frataxin increases sensitivity to oxidative stress, reduces lifespan, and causes lethality in a mitochondrial complex II mutant. FASEB J. 2006, 20: 172-174.PubMed Vázquez-Manrique RP, González-Cabo P, Ros S, Aziz H, Baylis HA, Palau F: Reduction of Caenorhabditis elegans frataxin increases sensitivity to oxidative stress, reduces lifespan, and causes lethality in a mitochondrial complex II mutant. FASEB J. 2006, 20: 172-174.PubMed
51.
go back to reference Piemonte F, Pastore A, Tozzi G, Tagliacozzi D, Santorelli FM, Carrozzo R, Casali C, Damiano M, Federici G, Bertini E: Glutathione in blood of patients with Friedreich's ataxia. Eur J Clin Invest. 2001, 31: 1007-1011. 10.1046/j.1365-2362.2001.00922.x.CrossRefPubMed Piemonte F, Pastore A, Tozzi G, Tagliacozzi D, Santorelli FM, Carrozzo R, Casali C, Damiano M, Federici G, Bertini E: Glutathione in blood of patients with Friedreich's ataxia. Eur J Clin Invest. 2001, 31: 1007-1011. 10.1046/j.1365-2362.2001.00922.x.CrossRefPubMed
52.
go back to reference Tozzi G, Nuccetelli M, Lo Bello M, Bernardini S, Bellincampi L, Ballerini S, Gaeta LM, Casali C, Pastore A, Federici G, Bertini E, Piemonte F: Antioxidant enzymes in blood of patients with Friedreich's ataxia. Arch Dis Child. 2002, 86: 376-379. 10.1136/adc.86.5.376.CrossRefPubMedPubMedCentral Tozzi G, Nuccetelli M, Lo Bello M, Bernardini S, Bellincampi L, Ballerini S, Gaeta LM, Casali C, Pastore A, Federici G, Bertini E, Piemonte F: Antioxidant enzymes in blood of patients with Friedreich's ataxia. Arch Dis Child. 2002, 86: 376-379. 10.1136/adc.86.5.376.CrossRefPubMedPubMedCentral
53.
go back to reference Sparaco M, Gaeta LM, Santorelli FM, Passarelli C, Tozzi G, Bertini E, Simonati A, Scaravilli F, Taroni F, Duyckaerts C, Feleppa M, Piemonte F: Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities. J Neurol Sci. 2009, 287: 111-118. 10.1016/j.jns.2009.08.052.CrossRefPubMed Sparaco M, Gaeta LM, Santorelli FM, Passarelli C, Tozzi G, Bertini E, Simonati A, Scaravilli F, Taroni F, Duyckaerts C, Feleppa M, Piemonte F: Friedreich's ataxia: oxidative stress and cytoskeletal abnormalities. J Neurol Sci. 2009, 287: 111-118. 10.1016/j.jns.2009.08.052.CrossRefPubMed
54.
go back to reference Haugen AC, Di Prospero NA, Parker JS, Fannin RD, Chou J, Meyer JN, Halweg C, Collins JB, Durr A, Fischbeck K, Van Houten B: Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology. PLoS Genet. 2010, 6: e1000812-10.1371/journal.pgen.1000812.CrossRefPubMedPubMedCentral Haugen AC, Di Prospero NA, Parker JS, Fannin RD, Chou J, Meyer JN, Halweg C, Collins JB, Durr A, Fischbeck K, Van Houten B: Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology. PLoS Genet. 2010, 6: e1000812-10.1371/journal.pgen.1000812.CrossRefPubMedPubMedCentral
55.
go back to reference Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, Sidi D, Munnich A, Rötig A: Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet. 1999, 354: 477-479. 10.1016/S0140-6736(99)01341-0.CrossRefPubMed Rustin P, von Kleist-Retzow JC, Chantrel-Groussard K, Sidi D, Munnich A, Rötig A: Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet. 1999, 354: 477-479. 10.1016/S0140-6736(99)01341-0.CrossRefPubMed
56.
go back to reference Lodi R, Hart PE, Rajagopalan B, Taylor DJ, Crilley JG, Bradley JL, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM: Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann Neurol. 2001, 49: 590-596. 10.1002/ana.1001.CrossRefPubMed Lodi R, Hart PE, Rajagopalan B, Taylor DJ, Crilley JG, Bradley JL, Blamire AM, Manners D, Styles P, Schapira AH, Cooper JM: Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann Neurol. 2001, 49: 590-596. 10.1002/ana.1001.CrossRefPubMed
57.
go back to reference Rustin P: The use of antioxidants in Friedreich's ataxia treatment. Expert Opin Investig Drugs. 2003, 12: 569-575. 10.1517/13543784.12.4.569.CrossRefPubMed Rustin P: The use of antioxidants in Friedreich's ataxia treatment. Expert Opin Investig Drugs. 2003, 12: 569-575. 10.1517/13543784.12.4.569.CrossRefPubMed
58.
go back to reference González-Cabo P, Llorens JV, Palau F, Moltó MD: Friedreich ataxia: an update on animal models, frataxin function and therapies. Adv Exp Med Biol. 2009, 652: 247-261. 10.1007/978-90-481-2813-6_17.CrossRefPubMed González-Cabo P, Llorens JV, Palau F, Moltó MD: Friedreich ataxia: an update on animal models, frataxin function and therapies. Adv Exp Med Biol. 2009, 652: 247-261. 10.1007/978-90-481-2813-6_17.CrossRefPubMed
59.
go back to reference Hausse AO, Aggoun Y, Bonnet D, Sidi D, Munnich A, Rötig A, Rustin P: Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart. 2002, 87: 346-349. 10.1136/heart.87.4.346.CrossRefPubMedPubMedCentral Hausse AO, Aggoun Y, Bonnet D, Sidi D, Munnich A, Rötig A, Rustin P: Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart. 2002, 87: 346-349. 10.1136/heart.87.4.346.CrossRefPubMedPubMedCentral
60.
go back to reference Rustin P, Bonnet D, Rötig A, Munnich A, Sidi D: Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology. 2004, 62: 524-525.CrossRefPubMed Rustin P, Bonnet D, Rötig A, Munnich A, Sidi D: Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology. 2004, 62: 524-525.CrossRefPubMed
61.
go back to reference Lynch DR, Perlman SL, Meier T: A phase 3, double-blind, placebo-controlled trial of idebenone in Friedreich ataxia. Arch Neurol. 2010, 67: 941-947. 10.1001/archneurol.2010.168.CrossRefPubMed Lynch DR, Perlman SL, Meier T: A phase 3, double-blind, placebo-controlled trial of idebenone in Friedreich ataxia. Arch Neurol. 2010, 67: 941-947. 10.1001/archneurol.2010.168.CrossRefPubMed
62.
go back to reference Bénit P, El-Khoury R, Schiff M, Sainsard-Chanet A, Rustin P: Genetic background influences mitochondrial function: modeling mitochondrial disease for therapeutic development. Trends Mol Med. 2010, 16: 210-217. 10.1016/j.molmed.2010.03.001.CrossRefPubMed Bénit P, El-Khoury R, Schiff M, Sainsard-Chanet A, Rustin P: Genetic background influences mitochondrial function: modeling mitochondrial disease for therapeutic development. Trends Mol Med. 2010, 16: 210-217. 10.1016/j.molmed.2010.03.001.CrossRefPubMed
63.
go back to reference Meier T, Perlman SL, Rummey C, Coppard NJ, Lynch DR: Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study. J Neurol. Meier T, Perlman SL, Rummey C, Coppard NJ, Lynch DR: Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study. J Neurol.
64.
go back to reference Sörensen L, Ekstrand M, Silva JP, Lindqvist E, Xu B, Rustin P, Olson L, Larsson NG: Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci. 2001, 21: 8082-8090.PubMed Sörensen L, Ekstrand M, Silva JP, Lindqvist E, Xu B, Rustin P, Olson L, Larsson NG: Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice. J Neurosci. 2001, 21: 8082-8090.PubMed
65.
go back to reference Bénit P, Goncalves S, Dassa EP, Brière JJ, Rustin P: The variability of the Harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes. PLoS One. 2008, 3: e3208-10.1371/journal.pone.0003208.CrossRefPubMedPubMedCentral Bénit P, Goncalves S, Dassa EP, Brière JJ, Rustin P: The variability of the Harlequin mouse phenotype resembles that of human mitochondrial-complex I-deficiency syndromes. PLoS One. 2008, 3: e3208-10.1371/journal.pone.0003208.CrossRefPubMedPubMedCentral
66.
go back to reference Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM: Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol. 2006, 2: 551-558.CrossRefPubMed Herman D, Jenssen K, Burnett R, Soragni E, Perlman SL, Gottesfeld JM: Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat Chem Biol. 2006, 2: 551-558.CrossRefPubMed
67.
go back to reference Sturm B, Helminger M, Steinkellner H, Heidari MM, Goldenberg H, Scheiber-Mojdehkar B: Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor. Eur J Clin Invest. 2010, 40: 561-565. 10.1111/j.1365-2362.2010.02292.x.CrossRefPubMed Sturm B, Helminger M, Steinkellner H, Heidari MM, Goldenberg H, Scheiber-Mojdehkar B: Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor. Eur J Clin Invest. 2010, 40: 561-565. 10.1111/j.1365-2362.2010.02292.x.CrossRefPubMed
68.
go back to reference Seguin A, Bayot A, Dancis A, Rogowska-Wrzesinska A, Auchère F, Camadro JM, Bulteau AL, Lesuisse E: Overexpression of the yeast frataxin homolog (Yfh1): contrasting effects on iron-sulfur cluster assembly, heme synthesis and resistance to oxidative stress. Mitochondrion. 2009, 9: 130-138. 10.1016/j.mito.2009.01.007.CrossRefPubMed Seguin A, Bayot A, Dancis A, Rogowska-Wrzesinska A, Auchère F, Camadro JM, Bulteau AL, Lesuisse E: Overexpression of the yeast frataxin homolog (Yfh1): contrasting effects on iron-sulfur cluster assembly, heme synthesis and resistance to oxidative stress. Mitochondrion. 2009, 9: 130-138. 10.1016/j.mito.2009.01.007.CrossRefPubMed
69.
go back to reference Martin M, Colman MJ, Gómez-Casati DF, Lamattina L, Zabaleta EJ: Nitric oxide accumulation is required to protect against iron-mediated oxidative stress in frataxin-deficient Arabidopsis plants. FEBS Lett. 2009, 583: 542-548. 10.1016/j.febslet.2008.12.039.CrossRefPubMed Martin M, Colman MJ, Gómez-Casati DF, Lamattina L, Zabaleta EJ: Nitric oxide accumulation is required to protect against iron-mediated oxidative stress in frataxin-deficient Arabidopsis plants. FEBS Lett. 2009, 583: 542-548. 10.1016/j.febslet.2008.12.039.CrossRefPubMed
70.
go back to reference Runko AP, Griswold AJ, Min KT: Overexpression of frataxin in the mitochondria increases resistance to oxidative stress and extends lifespan in Drosophila. FEBS Lett. 2008, 582: 715-719. 10.1016/j.febslet.2008.01.046.CrossRefPubMed Runko AP, Griswold AJ, Min KT: Overexpression of frataxin in the mitochondria increases resistance to oxidative stress and extends lifespan in Drosophila. FEBS Lett. 2008, 582: 715-719. 10.1016/j.febslet.2008.01.046.CrossRefPubMed
Metadata
Title
Friedreich's ataxia: the vicious circle hypothesis revisited
Authors
Aurélien Bayot
Renata Santos
Jean-Michel Camadro
Pierre Rustin
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2011
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-9-112

Other articles of this Issue 1/2011

BMC Medicine 1/2011 Go to the issue